Table 1 Correlation of clinicopathological features of HNSCC patients with GLUT4 expression
Clinicopathological feature | Number | GLUT4 expression, n (%) | P | |
|---|---|---|---|---|
Low (n = 23) | High (n = 67) | |||
Age (years) | ||||
 <65 | 72 | 19 (26.4) | 53 (73.6) | 0.717 |
 ≥65 | 18 | 4 (22.2) | 14 (77.8) |  |
Gender | ||||
 Male | 81 | 22 (27.2) | 59 (72.8) | 0.295 |
 Female | 9 | 1 (11.1) | 8 (88.9) |  |
T stage | ||||
 T1 + T2 | 64 | 17 (26.6) | 47 (73.4) | 0.731 |
 T3 + T4 | 26 | 6 (23.1) | 20 (76.9) |  |
N stage | ||||
 N0 | 63 | 16 (25.4) | 47 (74.6) | 0.958 |
 N1–3 | 27 | 7 (25.9) | 20 (74.1) |  |
M stage | ||||
 M0 | 88 | 23 (26.1) | 65 (73.9) | 0.402 |
 M1 | 2 | 0 (00.0) | 2 (100.0) |  |
Clinical stage | ||||
 I + II | 48 | 13 (27.1) | 35 (72.9) | 0.825 |
 III + IV | 40 | 10 (25.0) | 30 (75.0) |  |
Recurrence | ||||
 No | 33 | 15 (45.5) | 18 (54.5) | 0.001* |
 Yes | 57 | 8 (14.0) | 49 (86.0) |  |